Search by Drug Name or NDC

    NDC 00832-1410-03 Moxifloxacin Hydrochloride 5 mg/mL Details

    Moxifloxacin Hydrochloride 5 mg/mL

    Moxifloxacin Hydrochloride is a OPHTHALMIC SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Upsher-Smith Laboratories, LLC. The primary component is MOXIFLOXACIN HYDROCHLORIDE.

    Product Information

    NDC 00832-1410
    Product ID 0832-1410_b740604e-1d7a-4382-90ca-26b0186f7a93
    Associated GPIs 86101038102020
    GCN Sequence Number 052050
    GCN Sequence Number Description moxifloxacin HCl DROPS 0.5 % OPHTHALMIC
    HIC3 Q6W
    HIC3 Description OPHTHALMIC ANTIBIOTICS
    GCN 19542
    HICL Sequence Number 020690
    HICL Sequence Number Description MOXIFLOXACIN HCL
    Brand/Generic Generic
    Proprietary Name Moxifloxacin Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Moxifloxacin Hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SOLUTION
    Route OPHTHALMIC
    Active Ingredient Strength 5
    Active Ingredient Units mg/mL
    Substance Name MOXIFLOXACIN HYDROCHLORIDE
    Labeler Name Upsher-Smith Laboratories, LLC
    Pharmaceutical Class Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA212616
    Listing Certified Through 2024-12-31

    Package

    NDC 00832-1410-03 (00832141003)

    NDC Package Code 0832-1410-03
    Billing NDC 00832141003
    Package 1 BOTTLE, PLASTIC in 1 CARTON (0832-1410-03) / 3 mL in 1 BOTTLE, PLASTIC
    Marketing Start Date 2021-02-10
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 2.67778
    Pricing Unit ML
    Effective Date 2024-02-21
    NDC Description MOXIFLOXACIN 0.5% EYE DROPS
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1, 5
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis